Sellas Life Sciences Group, Inc. · NASDAQ:SLS
BlackRock, Inc. reported a 6.80% stake in Sellas Life Sciences Group, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 24, 2026
BlackRock, Inc. reported a 6.80% stake in Sellas Life Sciences Group, Inc., 12,136,331 shares, as a passive investor on Mar 31, 2026. Filed Apr 24, 2026 (Schedule 13G/A).
- Stake
- 6.80%
- Shares
- 12,136,331
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.80% | 12,136,331 |
Source
Related
- Sellas Life Sciences Group, Inc.
- BlackRock, Inc.
- Sellas Life Sciences Group, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Oct 17, 2025
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stergiou Angelos M. · Jun 18, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · Anson Funds Management LP · Feb 17, 2026